查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1968436

三尖瓣修復市场－全球产业规模、份额、趋势、机会与预测：按适应症、最终用途、地区和竞争格局划分，2021-2031年

Tricuspid Valve Repair Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Indication, By End Use, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 182 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

全球三尖瓣修復市场预计将从 2025 年的 6.6369 亿美元成长到 2031 年的 9.5796 亿美元，复合年增长率达到 6.31%。

此领域涵盖用于重建三尖瓣和纠正逆流而无需瓣膜置换的医疗设备和手术。市场成长的主要驱动力是老年人中心臟瓣膜疾病负担的日益加重。例如，根据欧洲心臟学会 (ESC) 2024 年的预测，75 岁以上族群中将有 4% 患有相关的三尖瓣逆流。除了庞大的患者群体外，微创导管治疗方法的日益普及（可缩短恢復时间）也极大地推动了市场发展。

市场概览
预测期 2027-2031
市场规模：2025年 6.6369亿美元
市场规模：2031年 9.5796亿美元
复合年增长率：2026-2031年 6.31%
成长最快的细分市场 三尖瓣逆流
最大的市场 北美洲

然而，三尖瓣固有的复杂解剖结构给市场扩张带来了巨大挑战，因为这使得器械固定和介入治疗过程中的可视化变得困难。克服这些挑战需要先进的影像基础设施和高度专业化的医生培训，而此类手术的实施通常仅限于大型学术机构。这些技术壁垒导致手术成本高昂，且在区域医院的普及率较低，阻碍了市场扩张所需的广泛应用。

市场驱动因素

经导管三尖瓣修復术 (TTVR) 的技术进步正在重塑市场格局，为高风险手术提供了有效的替代方案。近期监管部门的核准表明，相关设备能够有效应对三尖瓣复杂的解剖结构，从而推动了这项新治疗方法的商业化。根据爱德华生命科学公司 (Edwards Life Sciences) 2024 年 2 月发布的新闻稿，该公司首次核准了此类经导管治疗，使用 EVOQUE 系统治疗的患者中，约 99% 的重度逆流被减轻至中度或更轻。这种临床疗效正推动着该疗法的快速商业性化应用，爱德华生命科学公司 2024 年 10 月的报告显示，经导管二尖瓣和三尖瓣治疗的销售额增长了 73%，达到 9,100 万美元。

此外，三尖瓣逆流（TR）和心臟衰竭盛行率的上升凸显了巨大的未满足医疗需求。三尖瓣逆流常被称为“被遗忘的瓣膜”，它广泛影响老年患者群体，而由于手术风险，该群体历来缺乏治疗选择。疾病负担与介入率之间的差距是推动市场成长的关键因素。正如雅培公司在2024年4月宣布TriClip获得FDA核准的新闻稿中所述，光是美国就有超过160万人患有三尖瓣逆流。随着先进的诊断技术识别出更多可能受益于这种新核准的微创治疗的患者，市场将持续扩张，以满足这一庞大的患者群体的需求。

市场挑战

由于三尖瓣固有的复杂解剖结构，它对全球三尖瓣修復市场的成长构成了重大障碍。与其他心臟瓣膜不同，三尖瓣的结构高度可变，瓣叶脆弱，瓣环较大且不呈平面状，通常有三个或更多瓣叶。这种复杂的结构使得修復装置的固定极为困难，并且需要在手术过程中具备极佳的可视化能力。因此，有效的修復手术需要高度专业化的医生培训和先进的影像设备，例如术中经食道心臟超音波图。这些严格的技术要求使得此类手术只能在大型大学医院开展，阻碍了其在资源往往匮乏的地区性医院的广泛应用。

这种服务集中化造成了瓶颈，直接阻碍了市场成长。儘管瓣膜性心臟病发病率很高，但由于三尖瓣的解剖结构存在技术难题，手术数量相对于患者数量仍然非常低。根据2024年胸腔外科医师协会（STS）的数据，单纯三尖瓣手术仍有限，美国每年仅进行2,000多例。如此低的利用率表明，技术挑战以及由此导致的手术专属性阻碍了修復疗法的广泛普及和商业性扩充性。

市场趋势

人工智慧增强多重模式影像技术的整合正迅速成为一项关键趋势，直接解决了三尖瓣复杂解剖结构所带来的视觉化难题。为了克服手术过程中的引导困难，製造商正在将人工智慧融入超音波心动图系统，以实现影像识别和解剖结构量化的自动化。例如，西门子医疗在2024年8月的新闻稿中宣布，其新核准的ACUSON Origin系统已整合人工智慧辅助功能。该功能在场分类和多普勒定位方面达到了99%的准确率。这项技术进步降低了操作者差异，简化了工作流程，有助于实现经导管修復所需的精准定位。

同时，关键临床试验和上市后註册的加速推进，正在产生强有力的长期证据，以支持修復通讯协定的标准化和更广泛应用。随着市场走出最初的可行性阶段，大规模研究的成熟数据陆续发布，经导管缘对缘修復在不同真实世界患者群体中的持久性正得到证实。根据美国心臟学会于2024年8月发布的bRIGHT研究报告，雅培的TriClip系统展现持续的疗效，一年后81%的患者三尖瓣逆流程度降至中度或轻度。这些积极的临床结果在增强医生信心和确保市场扩张所需的保险覆盖方面发挥着至关重要的作用。

目录

第一章概述

第二章：调查方法

第三章执行摘要

第四章：客户心声

第五章：全球三尖瓣修復市场展望

  • 市场规模及预测
    • 按金额
  • 市占率及预测
    • 适应症（三尖瓣逆流、三尖瓣狭窄）
    • 依应用领域（医院、门诊手术中心（ASC）、其他）
    • 按地区
    • 按公司（2025 年）
  • 市场地图

第六章：北美三尖瓣修復市场展望

  • 市场规模及预测
  • 市占率及预测
  • 北美洲：国别分析
    • 我们
    • 加拿大
    • 墨西哥

第七章：欧洲三尖瓣修復市场展望

  • 市场规模及预测
  • 市占率及预测
  • 欧洲：国别分析
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙

第八章：亚太地区三尖瓣修復市场展望

  • 市场规模及预测
  • 市占率及预测
  • 亚太地区：国别分析
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲

第九章：中东和非洲三尖瓣修復市场展望

  • 市场规模及预测
  • 市占率及预测
  • 中东与非洲：国别分析
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非

第十章：南美洲三尖瓣修復市场展望

  • 市场规模及预测
  • 市占率及预测
  • 南美洲：国别分析
    • 巴西
    • 哥伦比亚
    • 阿根廷

第十一章 市场动态

  • 促进因素
  • 任务

第十二章 市场趋势与发展

  • 併购
  • 产品发布
  • 近期趋势

第十三章：全球三尖瓣修復市场：SWOT分析

第十四章：波特五力分析

  • 产业竞争
  • 新进入者的潜力
  • 供应商的议价能力
  • 顾客权力
  • 替代品的威胁

第十五章 竞争格局

  • Medtronic Plc
  • Edwards Lifesciences Corporation
  • LivaNova Plc
  • Abbott Laboratories Inc.
  • Corcym UK Limited
  • Micro Interventional Devices, Inc.
  • 4C Medical Technologies, Inc.
  • Venus Medtech（Hangzhou）Inc.
  • TRiCares GmbH
  • Trisol Medical

第十六章 策略建议

第十七章：关于研究公司及免责声明

简介目录
Product Code: 24064

The Global Tricuspid Valve Repair Market is projected to expand from USD 663.69 Million in 2025 to USD 957.96 Million by 2031, achieving a CAGR of 6.31%. This sector encompasses medical devices and procedural techniques designed to reconstruct the tricuspid valve and correct regurgitation without requiring replacement. Market growth is primarily fueled by the increasing burden of valvular heart disease among the geriatric population. For instance, the European Society of Cardiology estimated in 2024 that relevant tricuspid regurgitation affects 4% of individuals over the age of 75. This significant patient base, combined with a growing preference for minimally invasive transcatheter therapies that offer reduced recovery times, provides strong support for market development.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 663.69 Million
Market Size 2031USD 957.96 Million
CAGR 2026-20316.31%
Fastest Growing SegmentTricuspid Valve Regurgitation
Largest MarketNorth America

However, the inherent anatomical complexity of the tricuspid valve poses a substantial challenge to expansion, as it complicates device anchoring and visualization during interventions. Overcoming these difficulties requires advanced imaging infrastructure and highly specialized physician training, which often restricts the availability of these procedures to major academic centers. These technical barriers result in higher procedural costs and slower adoption rates in community hospital settings, thereby hindering the widespread accessibility necessary for broader market growth.

Market Driver

Technological advancements in Transcatheter Tricuspid Valve Repair (TTVR) are reshaping the market by offering viable alternatives to high-risk surgical procedures. Recent regulatory approvals have validated devices capable of addressing the complex anatomy of the tricuspid valve, enabling the commercialization of new therapies. According to an Edwards Lifesciences press release in February 2024 regarding the first FDA approval for such a transcatheter therapy, approximately 99 percent of patients treated with the EVOQUE system saw severe leakage reduced to moderate levels or less. This clinical efficacy is driving rapid commercial adoption, as evidenced by Edwards Lifesciences' October 2024 report, which showed a 73 percent increase in Transcatheter Mitral and Tricuspid Therapies sales to 91 million dollars.

Additionally, the rising prevalence of tricuspid regurgitation (TR) and heart failure highlights a massive unmet need. Often referred to as the "forgotten valve," TR affects a large geriatric patient population that has historically lacked treatment options due to surgical risks. This gap between disease burden and intervention rates serves as a critical catalyst for growth. As noted by Abbott in an April 2024 press release announcing FDA approval for TriClip, tricuspid regurgitation affects more than 1.6 million people in the U.S. alone. As advanced diagnostics identify more eligible candidates for these newly approved minimally invasive repairs, the market is expanding to accommodate this substantial patient pool.

Market Challenge

The inherent anatomical complexity of the tricuspid valve represents a significant barrier to the growth of the Global Tricuspid Valve Repair Market. Unlike other cardiac valves, the tricuspid valve features a highly variable structure with fragile leaflets and a large, non-planar annulus, often presenting with three or more leaflets. These intricacies significantly complicate the anchoring of repair devices and necessitate exceptional visualization capabilities during interventions. Consequently, effective repair procedures demand highly specialized physician training and advanced imaging infrastructure, such as intraprocedural transesophageal echocardiography. These stringent technical requirements effectively limit the availability of these procedures to major academic medical centers, preventing their widespread adoption in community hospitals where such resources may be scarce.

This concentration of service availability creates a bottleneck that directly impedes market growth. Despite the high prevalence of valvular disease, the technical difficulties associated with tricuspid anatomy result in procedural volumes that are disproportionately low relative to the patient population. Data from the Society of Thoracic Surgeons in 2024 indicates that isolated tricuspid valve surgeries remain limited, with just over 2,000 cases performed annually in the United States. This low utilization rate demonstrates how technical challenges and the resulting procedural exclusivity are stalling the broader accessibility and commercial scalability of repair therapies.

Market Trends

The integration of AI-enhanced multimodality imaging is rapidly emerging as a critical trend, directly addressing the visualization challenges associated with the complex anatomy of the tricuspid valve. To overcome the difficulties of intra-procedural guidance, manufacturers are embedding artificial intelligence into echocardiography systems to automate view recognition and anatomical quantification. For example, Siemens Healthineers announced in an August 2024 press release that their newly cleared ACUSON Origin system features AI Assist capabilities, demonstrating a 99 percent accuracy rate for view classification and Doppler placement. This technological advancement reduces operator variability and streamlines workflow, thereby facilitating the precise anchoring required for effective transcatheter repair.

Concurrently, the acceleration of pivotal clinical trials and post-market registries is generating the robust long-term evidence needed to standardize repair protocols and support wider adoption. As the market moves beyond early feasibility stages, the release of mature data from large-scale studies is validating the durability of transcatheter edge-to-edge repair in diverse, real-world patient populations. According to an August 2024 report from the American College of Cardiology regarding the bRIGHT study, the Abbott TriClip system demonstrated sustained efficacy, with 81 percent of patients achieving tricuspid regurgitation of moderate or less at one year. These positive clinical outcomes are instrumental in building physician confidence and securing the reimbursement necessary for market expansion.

Key Market Players

  • Medtronic Plc
  • Edwards Lifesciences Corporation
  • LivaNova Plc
  • Abbott Laboratories Inc.
  • Corcym UK Limited
  • Micro Interventional Devices, Inc.
  • 4C Medical Technologies, Inc.
  • Venus Medtech (Hangzhou) Inc.
  • TRiCares GmbH
  • Trisol Medical

Report Scope

In this report, the Global Tricuspid Valve Repair Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Tricuspid Valve Repair Market, By Indication

  • Tricuspid Valve Regurgitation
  • Tricuspid Valve Stenosis

Tricuspid Valve Repair Market, By End Use

  • Hospitals
  • Ambulatory Surgical Centers {ASCs}
  • Others

Tricuspid Valve Repair Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Tricuspid Valve Repair Market.

Available Customizations:

Global Tricuspid Valve Repair Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Tricuspid Valve Repair Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Indication (Tricuspid Valve Regurgitation, Tricuspid Valve Stenosis)
    • 5.2.2. By End Use (Hospitals, Ambulatory Surgical Centers {ASCs}, Others)
    • 5.2.3. By Region
    • 5.2.4. By Company (2025)
  • 5.3. Market Map

6. North America Tricuspid Valve Repair Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Indication
    • 6.2.2. By End Use
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Tricuspid Valve Repair Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Indication
        • 6.3.1.2.2. By End Use
    • 6.3.2. Canada Tricuspid Valve Repair Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Indication
        • 6.3.2.2.2. By End Use
    • 6.3.3. Mexico Tricuspid Valve Repair Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Indication
        • 6.3.3.2.2. By End Use

7. Europe Tricuspid Valve Repair Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Indication
    • 7.2.2. By End Use
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Tricuspid Valve Repair Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Indication
        • 7.3.1.2.2. By End Use
    • 7.3.2. France Tricuspid Valve Repair Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Indication
        • 7.3.2.2.2. By End Use
    • 7.3.3. United Kingdom Tricuspid Valve Repair Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Indication
        • 7.3.3.2.2. By End Use
    • 7.3.4. Italy Tricuspid Valve Repair Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Indication
        • 7.3.4.2.2. By End Use
    • 7.3.5. Spain Tricuspid Valve Repair Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Indication
        • 7.3.5.2.2. By End Use

8. Asia Pacific Tricuspid Valve Repair Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Indication
    • 8.2.2. By End Use
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Tricuspid Valve Repair Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Indication
        • 8.3.1.2.2. By End Use
    • 8.3.2. India Tricuspid Valve Repair Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Indication
        • 8.3.2.2.2. By End Use
    • 8.3.3. Japan Tricuspid Valve Repair Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Indication
        • 8.3.3.2.2. By End Use
    • 8.3.4. South Korea Tricuspid Valve Repair Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Indication
        • 8.3.4.2.2. By End Use
    • 8.3.5. Australia Tricuspid Valve Repair Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Indication
        • 8.3.5.2.2. By End Use

9. Middle East & Africa Tricuspid Valve Repair Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Indication
    • 9.2.2. By End Use
    • 9.2.3. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Tricuspid Valve Repair Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Indication
        • 9.3.1.2.2. By End Use
    • 9.3.2. UAE Tricuspid Valve Repair Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Indication
        • 9.3.2.2.2. By End Use
    • 9.3.3. South Africa Tricuspid Valve Repair Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Indication
        • 9.3.3.2.2. By End Use

10. South America Tricuspid Valve Repair Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Indication
    • 10.2.2. By End Use
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Tricuspid Valve Repair Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Indication
        • 10.3.1.2.2. By End Use
    • 10.3.2. Colombia Tricuspid Valve Repair Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Indication
        • 10.3.2.2.2. By End Use
    • 10.3.3. Argentina Tricuspid Valve Repair Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Indication
        • 10.3.3.2.2. By End Use

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Tricuspid Valve Repair Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Medtronic Plc
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Edwards Lifesciences Corporation
  • 15.3. LivaNova Plc
  • 15.4. Abbott Laboratories Inc.
  • 15.5. Corcym UK Limited
  • 15.6. Micro Interventional Devices, Inc.
  • 15.7. 4C Medical Technologies, Inc.
  • 15.8. Venus Medtech (Hangzhou) Inc.
  • 15.9. TRiCares GmbH
  • 15.10. Trisol Medical

16. Strategic Recommendations

17. About Us & Disclaimer